Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Trellus HealthLSE:TRLS 5-Year ROIIC % is 0.00 as of Dec. 2024. The stock has 2 warning signs investors should review. Among 529 Healthcare Providers & Services companies, Trellus Health ranks worse than 189035.73% on this metric.
5-Year Return on Invested Incremental Capital (5-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 5-year.
Trellus Health does not have enough data to calculate 5-Year ROIIC %.
Trellus Health (LSE:TRLS) 5-Year ROIIC % Explanation
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Trellus Health 5-Year ROIIC % Related Terms
Trellus Health 5-Year ROIIC % Historical Data
* Premium members only.
The historical data trend for Trellus Health's 5-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LSE:TRLS vs VEEV, BTSG, TEM: 5-Year ROIIC % Comparison
For the Health Information Services subindustry, Trellus Health's 5-Year ROIIC %, along with its competitors' market caps and 5-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Trellus Health 5-Year ROIIC % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Trellus Health's 5-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Trellus Health's 5-Year ROIIC % falls into.
Trellus Health's 5-Year ROIIC % for the quarter that ended in Dec. 2024 is calculated as:
5-Year ROIIC %
=
5-Year Incremental Net Operating Profit After Taxes (NOPAT)**
/
5-Year Incremental Invested Capital**
=
( -6.349 (Dec. 2024) - (Dec. 2019) )
/
( 6.242 (Dec. 2024) - (Dec. 2019) )
=
/
=
N/A%***
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 5-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Trellus Health (LSE:TRLS) has a 5-Year ROIIC % of 0.00 as of Dec. 2024. 5-Year ROIIC % measures the change in earnings as a percentage of change in investment over 5-year. View historical data on Trellus Health and its competitors. According to the industry distribution chart, Trellus Health ranks #999999 out of 529 companies in the Healthcare Providers & Services industry.
Is Trellus Health's 5-Year ROIIC % too high?
Trellus Health's current 5-Year ROIIC % is 0.00. Based on the distribution chart, Trellus Health ranks #999999 out of 529 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers.
How does Trellus Health's 5-Year ROIIC % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Trellus Health ranks #999999 out of 529 companies for 5-Year ROIIC %. This places Trellus Health in the lower half of its industry. The industry median 5-Year ROIIC % is 3.23. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year ROIIC % for a Healthcare Providers & Services company?
The median 5-Year ROIIC % among Healthcare Providers & Services companies is 3.23, based on 529 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year ROIIC % mean?
A high 5-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 5-Year ROIIC % measures the change in earnings as a percentage of change in investment over 5-year. View historical data on Trellus Health and its competitors. For the Healthcare Providers & Services industry, the median 5-Year ROIIC % is 3.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Trellus Health's current 5-Year ROIIC % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Trellus Health stock overvalued right now?
Trellus Health (LSE:TRLS) has a current 5-Year ROIIC % of 0.00. The current 5-Year ROIIC % is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year ROIIC % calculated?
5-Year ROIIC % is calculated from a company's financial statements. For Trellus Health (LSE:TRLS), the current 5-Year ROIIC % is 0.00 as of Dec. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Trellus Health PLC is commercializing the provision of digital chronic condition management solutions for employers and health plans that utilize the scientifically validated GRITT resilience-based methodology and a proprietary HIPAA-compliant technology platform called TrellusElevate to coordinate and deliver personalized care. The company is initially focused on Inflammatory Bowel Diseases, which include the chronic incurable conditions of Crohn's Disease and ulcerative colitis but considers its approach to have potential utility and demand across many chronic conditions.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LSE:TRLS has been successfully added to your 
